A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Clinical trial NCT02591095 · COMPLETED
Trial details
- NCT number
- NCT02591095
- Sponsor
- Centre Francois Baclesse
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-04-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.